NASDAQ: LMAT · Industrial Applications and Services · 3 alerts · CIK 1158895
Share price
$77.01Close, Nov 16
Market cap
$1.76B
Shares outstanding
22.88MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lemaitre Vascular Inc filings on SEC EDGAR ↗
LeMaitre Vascular reported net sales of $68.0 million for Q3 2026, a 11% increase over the prior year, though net income decreased to $15.0 million from $17.4 million. For the nine months ended September 30, 2026, the company saw improved profitability with net income rising to $47.8 million compared to $42.2 million in the same period of 2025.
LeMaitre Vascular reported Q3 2026 sales of $68.0 million, an 11% increase driven by strong performance in grafts and shunts. The company also announced the $19.2 million acquisition of vascular assets from B. Braun and declared a quarterly dividend of $0.25 per share.
Term
Q3 2026
“We expect 2026 to be another year of healthy sales (+11%) and EPS growth (+18%). Biologics continue to drive sales due to Artegraft’s international launch and the continued growth of RestoreFlow Allografts. The acquired B. Braun products will strengthen our core vascular portfolio while leveraging our expanding 31-country sales force.”
David B. Roberts notified the company of his intent to retire as President effective December 31, 2026, after 29 years of executive service. Mr. Roberts will continue to serve on the Board of Directors following his retirement as an employee.